Kiffik Biomedical, Inc. (“Kiffik”) is a biotechnology company that has developed a revolutionary technology based on the continuous extraction of native Interstitial Fluid (ISF) that will transform the medical, life science, and health monitoring industries. ISF is an information-rich biofluid that has been inaccessible for continuous extraction and analysis, until now. Kiffik has developed a wearable, non-invasive technology which provides continuous access to native interstitial fluid in humans and animals. This technology will revolutionize the collection of ISF, will lead to better quality of life for patients, and will facilitate faster therapeutic developments in the medical and life sciences.

Kiffik is at the forefront of the industry, developing methods and devices which are wearable, non-invasive, and provide continuous access to native interstitial fluid in humans and animals. Kiffik’s advanced technology will revolutionize the collection of ISF, leading to an improved quality of life for patients and facilitating faster therapeutic developments in the medical and life sciences. Kiffik intends to license its IP and become the “engine” behind advancements in new personal health monitoring platforms and processes to speed medical and life science developments.